Acetylcholine mediated vasodilatation in the microcirculation of patients with chronic fatigue syndrome

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 4, 2004, Pages 403-407

  Spence, V A ^a   Khan, F ^a   Kennedy, G ^a   Abbot, N C ^a   Belch, J J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AUTOANTIBODY; BRADYKININ RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; FATTY ACID; MUSCARINIC RECEPTOR; NITRIC OXIDE; SUBSTANCE P RECEPTOR;

AUTOIMMUNITY; BRAIN BLOOD FLOW; BRAIN MICROCIRCULATION; CHOLINERGIC SYSTEM; CHRONIC FATIGUE SYNDROME; CONFERENCE PAPER; DRUG SENSITIVITY; HUMAN; HYPOTHESIS; NEUROMUSCULAR FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; TRAINING; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 1842505974     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.12.016     Document Type: Conference Paper

References (27)

1. K. Fukuda, S. Straus, I. Hickie, The International Chronic Fatigue Syndrome Study Group. Chronic fatigue syndrome: a comprehensive approach to its definition and study, Ann. Int. Med. 121 (1994) 953-959.
2. A. Chaudhuri, T. Majeed, T. Dinan, P.O. Behan, Chronic fatigue syndrome: a disorder of central cholinergic transmission, J. Chronic Fatigue Syndrome 3 (1997) 3-16.
3. A. Tomoda, T. Miike, E. Yamada, et al., Chronic fatigue syndrome in childhood, Brain Dev. 22 (2002) 60-64.
4. B.K. Puri, S.J. Counsell, R. Zaman, et al., Relative increase in choline in the occipital cortex in chronic fatigue syndrome, Acta Psychiatr. Scand. 106 (2002) 224-226.
5. A. Chaudhuri, B.R. Cindon, J.W. Gow, D. Brennan, D.M. Hadley, Proton magnetic resonance of basal ganglia in chronic fatigue syndrome, Neuroreport 14 (2003) 225-228.
6. S. Tanaka, H. Kuratsune, Y. Hidaka, Y. Hakariya, et al., Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome, Int. J. Mol. Med. 12 (2003) 225-230.
7. V.A. Spence, F. Khan, J.J.F. Belch, Enhanced sensitivity of the peripheral cholinergic vascular response in patients with chronic fatigue syndrome, Am. J. Med. 108 (2000) 736-739.
8. D.J. Newton, F. Khan, J.J.F. Belch, Assessment of microvascular endothelial function in human skin, Clin. Sci. 101 (2001) 567-572.
9. L.G. Heaney, L.J. Cross, C.F. Stanford, M. Ennis, Substance P induces histamine release from human pulmonary mast cells, Clin. Exp. Allergy 25 (1995) 179-186.
10. L. Dechene, Chronic fatigue syndrome: influence of histamine hormones and electrolytes, Med. Hypotheses 40 (1993) 55-60.
11. P. Steinberg, B.E. McNutt, P. Marshall, et al., Double-blind placebo controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome, J. Allergy Clin. Immunol. 97 (1996) 119-126.
12. F. Khan, V.A. Spence, G. Kennedy, J.J.F. Belch, Prolonged acetylcholine-induced vasodilatation in the peripheral microcirculation of patients with chronic fatigue syndrome, Clin. Physiol. Funct. Imaging 23 (2003) 282-285.
13. C.J. Kirkpatrick, F. Bittinger, R.E. Unger, et al., The non-neuronal cholinergic system in the endothelium: evidence and possible pathobiological significance, Jpn. J. Pharmacol. 85 (2001) 24-28.
14. R. Rubenstein, R.W. Price, Early inhibition of acetylcholinesterase and choline acetyltransferase activity in Herpes simplex virus type 1 infection of PC12 cells, J. Neurochem. 42 (1984) 142-150.
15. M.B.A. Oldstone, J. Holmstoen, R.M. Welsh, Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocyctic choriomeningitis virus, J. Cell Physiol. 91 (1997) 459-472.
16. R.F. Witter, Measurement of Blood Cholinesterase, Arch. Environ. Health 6 (1963) 537-553.
17. F. Khan, G. Kennedy, V.A. Spence, D.J. Newton, J.J.F. Belch. Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome, and with illness following organophosphate exposure. Clin. Sci. 106 (2004) 183-189.
18. G. Kennedy, N.C. Abbot, V.A. Spence, C. Underwood, J.J.F. Belch, The specificity of the CDC-1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria. Ann. Epidemiol., in press.
19. J. Bauersachs, R. Popp, M. Hecker, E. Sauer, I. Fleming, R. Busse, Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor, Circulation 94 (1996) 3341-3347.
20. J. Quilley, D. Fulton, J.C. McGiff, Hyperpolarizing factors, Biochem. Pharmacol. 54 (1997) 1059-1070.
21. D.R. Harder, W.B. Campbell, R.J. Roman, Role of cytochrome P-450 enzymes and metbolites of arachidonic acid in the control of vascular tone, J. Vasc. Res. 32 (1995) 79-92.
22. A.W. Al-Allaf, F. Khan, J. Moreland, J.J.F. Belch, Investigation of cutaneous microvascular activity and flare response in patients with fibromyalgia syndrome, Rheumatology 40 (2001) 1097-1101.
23. S.J. Morris, A.C. Shore, J.E. Tooke, Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with IDDM, Diabetologia 38 (1995) 1337-1344.
24. F. Khan, S.J. Litchfield, P.A. Stonebridge, J.J.F. Belch, Lipid lowering and skin vascular responses in patients with hypercholesterolemia and peripheral arterial obstructive disease, Vasc. Med. 4 (1999) 233-238.
25. F. Khan, T.A. Elhadd, S.A. Greene, J.J.F. Belch, Impaired skin microvascular function in children, adolescents and young adults with type 1 diabetes, Diabetes Care 23 (2000) 215-220.
26. H.D. Kvernmo, A. Stefanovska, K.A. Kirkebùen, B. Østerud, K. Kvernebo, Enhanced endothelium-dependent vasodilatation in human skin vasculature induced by physical conditioning, Eur. J. Appl. Physiol. 79 (1998) 30-36.
27. Y. Kawamura, M. Kihara, K. Nishimoto, M. Taki, Efficacy of a half dose of oral pyridostigmine in the treatment of chronic fatigue syndrome: three case reports, Pathophysiology 9 (2003) 189-194.